Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
- Sonnenblick, A.
- Francis, P.A.
- Azim, H.A.
- De Azambuja, E.
- Nordenskjöld, B.
- Gutiérez, J.
- Quinaux, E.
- Mastropasqua, M.G.
- Ameye, L.
- Anderson, M.
- Lluch, A.
- Gnant, M.
- Goldhirsch, A.
- Di Leo, A.
- Barnadas, A.
- Cortes-Funes, H.
- Piccart, M.
- Crown, J.
ISSN: 1879-0852, 0959-8049
Année de publication: 2015
Volumen: 51
Número: 12
Pages: 1481-1489
Type: Article